Metabolism - Clinical and Experimental
Volume 44, Issue 6 , Pages 725-729 , June 1995

Effect of short-term treatment with recombinant human growth hormone on lipids and lipoproteins in women and men without growth hormone disturbances

Received 1 April 1994 ,Accepted 8 September 1994.

References 

  1. Nikkilä EA, Pelkonen R. Serum lipids in acromegaly. Metabolism. 1975;7:829–838
  2. Rosén T, Bengtsson B-Å. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet. 1990;336:285–288
  3. Merimee TJ, Hollander W, Fineberg SE. Studies of hyperlipidemia in the HGH-deficient state. Metabolism. 1972;21:1053–1061
  4. Winter RJ, Green OC. Effect of thyroxine and growth hormone on the hypercholesterolemia of growth hormone deficiency. Metabolism. 1984;33:54–57
  5. Salomon F, Cuneo RC, Hesp R, et al.  The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med. 1989;321:1797–1803
  6. Blackett PR, Weech PK, McConathy WJ, et al.  Growth hormone in the regulation of hyperlipidemia. Metabolism. 1982;31:117–120
  7. Edén S, Wiklund O, Oscarsson J, et al.  Growth hormone treatment of growth hormone—deficient adults results in a marked increase in Lp(a) and HDL cholesterol concentrations. Arterioscler Thromb. 1993;13:296–301
  8. Asayama K, Amemiya S, Kusano S, et al.  Growth-hormone-induced changes in postheparin plasma lipoprotein lipase and hepatic triglyceride lipase activities. Metabolism. 1984;33:129–131
  9. Hintz RL, Wilson DM, Finno J, et al.  Biosynthetic methionyl human growth hormone is biologically active in adult man. Lancet. 1982;5:1276–1279
  10. Cohen R, Chanson P, Bruckert E, et al.  Effects of octreotide on lipid metabolism in acromegaly. Horm Metab Res. 1992;24:397–400
  11. Friedman M, Byers SO, Rosenman RH, et al.  Effect of subacute administration of human growth hormone on various serum lipid and hormone levels of hypercholesterolemic and normocholesterolemic subjects. Metabolism. 1974;23:905–912
  12. Olivecrona H, Ericsson S, Berglund L, et al.  Increased concentrations of serum lipoprotein(a) in response to growth hormone treatment. Br Med J. 1993;306:1726–1727
  13. Möller A, Rasmussen LM, Thuesen L, et al.  Impact of human growth hormone on plasma lipoprotein concentrations. Horm Metab Res. 1989;21:207–209
  14. Brixen K, Kassem M, Eriksen EF, et al.  Growth hormone (GH) and adult bone remodeling: The potential use of GH in treatment of osteoporosis. J Pediatr Endocrinol. 1993;6:65–71
  15. Brixen K, Kassem M, Nielsen HK, et al: Short term treatment with growth hormone stimulates osteoblastic and osteoclastic activity in osteopenic postmenopausal women. A dose response study. (submitted)
  16. Brixen K, Nielsen HK, Mosekilde L, et al.  A short course of recombinant human growth hormone stimulates osteoclasts and activates bone remodeling in normal human volunteers. J Bone Miner Res. 1990;5:609–618
  17. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1992;18:499–502
  18. Klausen IC, Gerdes LU, Berg Schmidt E, et al.  Differences in apolipoprotein(a) polymorphism in West Greenland Eskimos and caucasian Danes. Hum Genet. 1992;89:384–388
  19. Kraft H-G, Dieplinger H, Hoye E, et al.  Lp(a) phenotyping by immunoblotting with polyclonal and monoclonal antibodies. Arteriosclerosis. 1988;8:212–216
  20. Utermann G, Menzel HJ, Kraft HG, et al.  Lp(a) glycoprotein phenotypes: Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invest. 1987;80:458–465
  21. Raben MS, Hollenberg CH. Effect of growth hormone on plasma fatty acids. J Clin Invest. 1959;38:484–488
  22. Pittner RA, Bracken P, Fears R, et al.  Insulin antagonises the growth hormone-mediated increase in the activity of phosphatidate phosphohydrolase in isolated rat hepatocytes. FEBS Lett. 1986;202:133–136
  23. Elam MB, Simkevich CP, Solomon SS, et al.  Stimulation of in vitro triglyceride synthesis in the rat hepatocyte by growth hormone treatment in vivo. Endocrinology. 1988;122:1397–1402
  24. Sjöberg A, Oscarsson J, Boström K, et al.  Effects of growth hormone on apolipoprotein B (apoB) messenger ribonucleic acid editing, and apoB 48 and apoB 100 synthesis and secretion in the rat liver. Endocrinology. 1992;130:3356–3364
  25. Oscarsson J, Olofsson S-O, Vikman K, et al.  Growth hormone regulation of serum lipoproteins in the rat: Different growth hormone regulatory principles for apolipoprotein (apo) B and the sexually dimorphic apo E concentrations. Metabolism. 1991;40:1191–1198
  26. Tall AR. Metabolic and genetic control of HDL cholesterol levels. J Int Med. 1992;231:661–668
  27. Rudling M, Norstedt G, Olivecrona H, et al.  Importance of growth hormone for the induction of hepatic low density lipoprotein receptors. In: ed 2. Proc Natl Acad Sci USA. 89:1992;p. 6983–6987
  28. Beher WT, Beher ME, Semenuk G. The effect of pituitary and thyroid hormones on bile acid metabolism in the rat. Metabolism. 1966;15:181–188
  29. Utermann G. The mysteries of lipoprotein(a). Science. 1989;246:904–910
  30. Vessby B, Kostner G, Lithell H, et al.  Diverging effects of cholestyramine on apolipoprotein B and lipoprotein Lp(a). Atherosclerosis. 1982;44:61–71
  31. Klausen IC, Gerdes LU, Meinertz H, et al.  Apolipoprotein(a) polymorphism predicts the increase of Lp(a) by pravastatin in patients with familial hypercholesterolemia treated with bile acid sequestration. Eur J Clin Invest. 1993;23:240–247
  32. Soutar AK, McCarthy SN, Seed M, et al.  Relationship between apolipoprotein(a) phenotype, lipoprotein(a) concentration in plasma and low density lipoprotein (LDL) receptor function in a large kindred with familial hypercholesterolemia due to the Pro664-Leu mutation in the LDL-receptor gene. J Clin Invest. 1991;88:483–492
  33. Carlson LA, Hamsten A, Asplund A. Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidemic subjects treated with nicotinic acid. J Intern Med. 1989;226:271–276
  34. Hochberg Z, Hertz P, Maor G, et al.  Growth hormone and insulin-like growth factor-I increase macrophage uptake and degradation of low density lipoprotein. Endocrinology. 1992;131:430–435
  35. Steinberg D, Parthasarathy S, Carew TE, et al.  Beyond cholesterol: Modifications of low density lipoproteins that increases its atherogenicity. N Engl J Med. 1989;320:915–924

☆ Supported by The Danish Heart Foundation and Novo-Nordisk, Denmark.

PII: 0026-0495(95)90184-1

Metabolism - Clinical and Experimental
Volume 44, Issue 6 , Pages 725-729 , June 1995

Article Tools